The role of purinergic P2X7 receptors on lipopolysaccharide (LPS)-induced lung injury

V. Cagido, D. Riva, D. Fonseca, W. Zin, R. Coutinho-Silva, D. Faffe (Rio de Janeiro, Brazil)

Source: Annual Congress 2007 - Acute and chronic lung injury and its repair: novel molecular insight
Session: Acute and chronic lung injury and its repair: novel molecular insight
Session type: Oral Presentation
Number: 2693
Disease area: Airway diseases

Congress or journal article abstractSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Cagido, D. Riva, D. Fonseca, W. Zin, R. Coutinho-Silva, D. Faffe (Rio de Janeiro, Brazil). The role of purinergic P2X7 receptors on lipopolysaccharide (LPS)-induced lung injury. Eur Respir J 2007; 30: Suppl. 51, 2693

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Role of nicotinic receptors in the regulation of cytokines production by human lung macrophages
Source: Annual Congress 2012 - Mechanistic studies in airway cell biology
Year: 2012

The role of lipoxin A4 and its receptor in pathogenesis of inflammatory lung diseases
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010


The purinergic receptor P2Y2 mediates chemotaxis of dendritic cells and eosinophils in allergic lung inflammation
Source: Annual Congress 2010 - Asthma: basic science and clinical studies
Year: 2010

Preserved compliance and reduced inflammation after activation of peroxisome proliferator-activated receptor (PPAR)a in a murine model of acute lung injury
Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS)
Year: 2006


Serotonin (5-hydroxytryptamine) modulates cytokine and chemokine production in lipopolysaccharide-primed human monocytes via stimulation of different 5-HT receptor subtypes
Source: Annual Congress 2005 - Inflammation and remodelling in allergy and asthma
Year: 2005


Influence of Toll-like receptor 4 (TLR4) on cellular signaling of acute lung injury
Source: Eur Respir J 2003; 22: Suppl. 45, 268s
Year: 2003

Effect of muscarinic receptors inhibition on cytokine release and inflammatory cells infiltration in the airway of cat as an animal model for COPD
Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Year: 2012


Synthetic cannabinoids induce acute lung inflammation via cannabinoid receptor 1 activation
Source: ERJ Open Res, 6 (3) 00121-2020; 10.1183/23120541.00121-2020
Year: 2020



Role of muscarinic receptors in airway inflammation and remodelling
Source: International Congress 2015 – Respiratory research in the Netherlands
Year: 2015


Toll-like receptor mRNA levels in alveolar macrophages after inhalation of endotoxin
Source: Eur Respir J 2006; 28: 622-626
Year: 2006



CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis
Source: Eur Respir J 2009; 34: 676
Year: 2009



Stimulation of acetylcholine receptors impairs host defence during pneumococcal pneumonia
Source: Eur Respir J 2009; 33: 375-381
Year: 2009



Altered expression of toll-like receptor (TLR)-2 and TLR-4 on alveolar macrophages (AM) in inflammatory lung disease
Source: Eur Respir J 2003; 22: Suppl. 45, 588s
Year: 2003

Chemokine receptors in a regulation of interstitial lung fibrosis and inflammation
Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease
Year: 2008


Role of Toll-like receptor 4 in acute pulmonary inflammation induced by bacterial components in mice
Source: Eur Respir J 2005; 26: Suppl. 49, 730s
Year: 2005

Role of NF-?B and PPAR-? in lung inflammation induced by monocyte-derived microparticles
Source: Eur Respir J 2011; 37: 1494-1502
Year: 2011



The pathway to inflammation in asthma: the role of the DP2 receptor
Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now?
Year: 2019

A novel receptor antagonist, c-027, inhibits airway contraction in human and murine models of allergen, independent of inflammatory mediator release
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009

Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice
Source: Eur Respir J 2008; 32: 426-436
Year: 2008



A role for PAR1 in lipopolysaccharide induced acute lung injury
Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon
Year: 2008